chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt received vaccine at 15:25.  At 15:33 pt. reported her lips felt tingly.  At 15:38 patient began seizing and was lowered to the ground by 2 staff members. Oxygen was placed on patient at 5L via nonrebreather mask.  Initial BP 160/80 manually on right arm, Heart rate 26, oxygen saturation 84%.  Oxygen increased to 10L and EPI 0.5 mg administered IM into right anterolateral by, APN at 15:43.  15:44 vitals: BP 182/90 manual R arm, 110 heart rate, 99% 02. Oxygen decreased to 8L.    Seizure ended at 15:45.  Vitals at 15:45 180/105 BP, 115 heart rate, 98% O2.Vitals at 15:48 185/100, HR 102, oxygen  99%. EMS arrived at 15:50 & 2nd seizure began at 15:50.  15:50 vitals BP 245/110, 131 HR, 99% O2.  15:52 vitals 240/110 BP, 107 HR, 99% 02. Pt. left via ambulance at 15:55.
Patient falsified birthdate on consent form in order to obtain vaccination prior to 12 years of age. Online insurance search matched with incorrect date of birth provided. Patient stated falsified birthdate during administration process.
Tdap and PNEUMOVAX injected into left deltoid on 5/14/15. Developed pain, swelling, fever, headache. Redness, swelling and pain were in (L) upper arm. Seen in emergency room - given diagnosis of cellulitis and prescribed BACTRIM.
16 year old male patient received first dose of Moderna vaccine. After discovering error, patient received 2nd dose per CDC recommendation.
Morning of Friday October 8, 2021 I awoke around 4 a.m. in the morning with severe chest pain.  I contacted my doctor and went to his office.  He sent me to Emergency Room where I several test.  The test conducted in the emergency room indicated a possible heart attack and I was admitted to the hospital.  After having a heart catherization to check blockage of arteries it was determine that was not the cash and a scan of my heart indicated inflammation of the membrane(s) surrounding my heart.  The doctors told me this was an issue they were seeing with persons who had received the Pfizer Covid vaccine.
This spontaneous report as received from a nurse refers to a patient of unknown age or gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, drug reactions or allergies. On 29-AUG-2017, the patient was vaccinated with improperly stored VARIVAX (exact dose, dose number, route of administration were not reported; lot # M035687 with the expiration date of 10-AUG-2018), for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (lot # and expiration date were not reported). No adverse effects were reported. The administered dose of VARIVAX underwent a temperature excursion between 6 and 14 degrees Fahrenheit for 20 days. There were no previous temperature excursions reported. Digital data logger was involved to capture the temperature excursion. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1709USA009779.
experienced arm pain for about a week; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis.   On an unknown date, the patient received Tdap Vaccine at an unknown dose. On an unknown date, unknown after receiving Tdap Vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Tdap Vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced arm pain for about a week after receiving Tdap vaccine of unknown manufacturer. The reporter did not consent to follow up. This case is 1 of the 4 cases, reported by same reporter.
redness at the injection site; swelling at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th July 2019, the patient received the 1st dose of Shingrix (intramuscular). On 29th July 2019, less than a day after receiving Shingrix, the patient experienced injection site erythema and injection site swelling. On an unknown date, the outcome of the injection site erythema and injection site swelling were recovering/resolving.   It was unknown if the reporter considered the injection site erythema and injection site swelling to be related to Shingrix.  Additional information received were as follows: The patient experienced  injection site erythema and injection site swelling. The redness was 1 to 1.5 inch round.
No Symptoms yet. Patient requested a Pfizer Bivalent Injection. I asked him which number shot, he replied 5th shot. He showed me the front of the card. I gave him the shot and while turning to back of the card I noticed he had already received the bivalent a another pharmacy ..he said he didn't remember
Swelling around area, Constant severe "itch"; Redness around site - 5cm diameter
Patient experienced throat tightness, chest tightness, anxiety, and lightheadedness that did not subside after 30 minute observation. She was transferred to the ED for further evaluation.
THE PATIENT CAME TO THE CLINIC  - HE CAME TO GET THE PFIZER VACCINE - WHEN ASKED IF IT WAS HIS FIRST DOSE HE SAID YES - DID NOT PRESENT A CARD - GAVE HIM HIS FIRST PFIZER DOSE - HE WAITED HIS 15 MINUTES THEN LEFT.  UPON ENTERING THE DOSE, IT WAS BROUGHT TO THE NURSES ATTENTION THE PATIENT ALREADY HAD A J&J DOSE.  WHEN GETTING BACK TO THE CLINIC, SUPERVIOSR WAS CONSULTED THE PATIENT WAS CONTACTED.  HE REPORTED HE DID NOT WORK AT (LOCATION REDACTED) WHEN ASKED.  WHEN ASKED IF HE HAD RECEIVED A J&J IN MARCH HE SAID YES.  HE SAID HIS DOCTOR RECOMMENDED HE GET A PFIZER.  THE PATIENT WOULD NOT SAY WHO HIS DOCTOR IS..PATIENT WAS INSTRUCTED TO NOT GET ANYMORE DOSES.  UPON FURTHER REVIEW AS WELL THE PATIENT DID NOT ANSWER IF HE HAD RECEIVED A COVID VACCINE YET OR NOT - HE LEFT IT BLANK.
Both arms began to shake about 45 minutes after receiving the shot and continued for approximately 30 minutes. The shaking was mild-moderate , she could continue her activities, but the right arm shook more than the left arm.
Right arm swelling, lymph node tenderness, generalized muscle aches 12 hrs following vaccine. No treatment.
Nausea and drowsiness; Nausea and drowsiness; This is a spontaneous report from a contactable consumer (medical assistant) via Pfizer sales representative.   A female patient of an unspecified age received the second dose of meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration at 0.5 ml, single on an unspecified date for immunisation .  The patient medical history and concomitant medications were not reported. The patient previously took the first dose of meningococcal group b rlp2086  for immunisation. The patient experienced nausea and drowsiness on an unspecified date. The patient recovered after a week with no medical treatment. The dose was the second dose given in a series 6 months after the first dose.  Information on the lot/ batch number has been requested
Extremely sore arm, felt heavy and trouble lifting it. Had red blotches a few inches from the injection site.  Had nausea and vomiting that evening (one time).
Pain at site; shortness of breath; palpitations; elevated blood pressure; positive D-dimer; tachycardia; abnormal ekg; headache; chest pain; achy; fatigue; fever; chills; Covid/Flu like symptoms; This is a spontaneous report from a contactable Other HCP (patient). A 49-year-old female patient received the second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration on 11Jan2021 at 13:00 at single dose in left arm for covid-19 immunization. Medical history included hypothyroidism, known allergies: penicillin and dexamethasone. Concomitant medication included thyroid (ARMOUR THYROID), lisdexamfetamine mesilate (VYVANSE), amitriptyline, zolpidem. The patient previously received the first dose bnt162b2 (lot number: EK5730) on 21Dec2020 at 13:00 in left arm for covid-19 immunization. The patient experienced pain at site, shortness of breath, palpitations, elevated blood pressure, positive D-dimer, tachycardia, abnormal EKG, headache, chest pain, achy, fatigue, fever, chills and Covid/Flu like symptoms; all on 12Jan2021 at 18:00. The events resulted on doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received treatment for the events with Sodium Chloride and Dulera Inhaler. The patient did not have COVID prior vaccination, the patient had been tested for COVID post vaccination, which included SARS-CoV-2 (Nasal Swab): negative on 15Jan2021, and Novel Coronovirus PCR (Blood test): negative on 15Jan2021. The outcome of all events was not resolved.
Local reaction on Rt thigh of redness and firm area at injection site. Area is not warm to touch. Mom has treated with cold packs, and TYLENOL. Influenza and MMR/V given in Rt. leg/thigh.
Patient developed progressively worsening redness + swelling that encompassed entire (R) upper extremity + shortness of breath treated w/ oral steroids + Albuterol
Pt was given MMR & PENTACEL on (R) leg on 2/20/2012. Pt developed leg/knee swelling & soreness to where he couldn't bear weight for 24h. Swelling has now decreased & pt is now bearing weight.
pain; redness; swelling; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain, erythema and swelling. On an unknown date, the outcome of the pain, erythema and swelling were unknown.   It was unknown if the reporter considered the pain, erythema and swelling to be related to Shingles vaccine.     Additional Information: GSK receipt date : 18-OCT-2022 Reporters comment: This case was reported by a consumer via interactive digital media. The patient received shingles vaccine and experienced pain redness and swelling.
COUGH IN MIDDLE OF CHEST IN HEART AREA AND IT LIKE SUNBURST; BURST OF ENERGY; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced cough in middle of chest in heart area and it like sunburst, and burst of energy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from cough in middle of chest in heart area and it like sunburst, and the outcome of burst of energy was not reported. This report was non-serious.
Erythema Rash macropapular with swelling, induration, high local temp. Right thigh (site of flu shot IM .5ml)
severe headache; severe nausea; severe vomiting; upper GI pain; tingling in hands and feet; weakness; fever; This is a spontaneous report from a contactable nurse (patient). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EK5730), via Intramuscular at single dose in the arm left, first dose on 17Dec2020 08:15, second dose on 07Jan2021 08:15, both for COVID-19 immunisation. Medical history included Epilepsy. Concomitant medications included fluvoxamine maleate (LUVOX), oxcarbazepine (OXTELLAR XR), liraglutide (SAXENDA) and bupropion hydrochloride, naltrexone hydrochloride (CONTRAVE). On 07Jan2021 17:00, the patient experienced severe headache, severe nausea, severe vomiting, upper gi pain, tingling in hands and feet, weakness, fever. The patient underwent lab tests and procedures, which included Nasal Swab on 08Jan2021 with negative result. Therapeutic measures were taken as a result of severe nausea and severe vomiting and included treatment with Zofran. Outcome of events was recovering.
Mild fever achiness but disabling neuropathy pain that will not subside in bilateral feet and ankles and one leg. (never had been like this before.) now going for day and a half none stop. Sugars extreme both directions with no change in diet.
Nausea, Light Headness, Extreme Tiredness, Unable to Concentrate, Tenderness at the Injection Site
rash about 2 inches in diameter around the injection site.; fatigued.; felt really itchy.; light headed; eye lids got very puffy looking; lips also swelled up; "This was her third VARIVAX vaccine; This spontaneous report has been received from the patient's mother (reported as on behalf of her daughter), referring to a 18 years old female patient. The patient's historical condition and concomitant medication were not provided.  On 16-MAY-2022, the patient was vaccinated with her third doe of varicella virus vaccine live (oka/merck) (VARIVAX) (dose, strength, route, lot number and expiration date were unknown) for prophylaxis (Extra dose administered). She received the diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) tetanus vaccine toxoid (TDAP) vaccine at the same time. She had a medical situation where she had to receive shots in her leg.  On the same day within a few minutes of her receiving the vaccine, the patient developed a rash about 2 inches in diameter around the injection site (Vaccination site rash). She felt really itchy (Pruritus). The reporter gave her 25mgs of diphenhydramine (BENADRYL) to try and help the itchy feeling.  Within about fifteen minutes of getting the vaccine, she started not feeling well. She felt light headed and fatigued (Dizziness and Fatigue). Within about twenty minutes after the injection, her eye lids got very puffy looking (Swelling of eyelid). Her lips also swelled up (Lip swelling). The reporter took her back to the doctors office and the nurse practitioner (NP) gave her another 25mgs of diphenhydramine (BENADRYL). After giving her more diphenhydramine (BENADRYL) the swelling went down. The NP told the reporter that it appeared the patient was not having an anaphylactic reaction. She felt better for a little while, but when the diphenhydramine (BENADRYL) ran out, she started to feel bad again. The reporter reached back out to the doctor and they suggested the reporter tried giving her cetirizine (ZYRTEC ) instead. So, the reporter had been giving her that every 12 hours for the past few days. She felt good in the morning, but when the cetirizine (ZYRTEC ) worn off she felt bad again. She was a vegan and had not had meat in a really long time. The reporter made an appointment with an allergist, but they had not been seen yet. The outcome of the events of vaccination site rash, lip swelling, swelling of eyelid, fatigue, dizziness and pruritus was considered as not recovered.  The causality assessment between the events of vaccination site rash, lip swelling, swelling of eyelid, fatigue, dizziness and pruritus and suspect vaccine was not reported.
Left arm red raised area 2 1/2 x 3 3/4, chest tight went to ER Keflex 500mg x 2 Benadryl 25mg BID.
Red, swelling, pain, warmth around shot site on back of right arm where SQ VARIVAX was given.
This is a prospective pregnancy case. This 39-year-old female subject was enrolled in a study. The subject received BOOSTRIX (intramuscular) on 5th January 2015. The subject's past medical history included live birth (The patient had 2 previous pregnancies with normal births). The subject's last menstrual period was on 2nd June 2014 and estimated date of delivery was 6th March 2015. The subject received BOOSTRIX at week 31 of the pregnancy and during the third trimester of pregnancy. On an unknown date, an unknown time after receiving BOOSTRIX the subject developed vaccine exposure during pregnancy (Non-serious). The outcome of vaccine exposure during pregnancy was unknown. The pregnancy was ongoing. Additional information received on 13 January 2015: The type of conception was normal. There was no evidence of a defect from prenatal testing. The mother wasn't using contraception. The number of gestational weeks was not reported but was calculated with the last menstrual period.
Fever of 104.8 degrees, irritability, fatigue, vomiting, headache, body aches, restless, upper respiratory issues, trouble breathing, wheezing, coughing, rash.
aches and sore arm after the vaccine; feels really achy, congested, sore throat; feels really achy, congested, sore throat; feels really achy, congested, sore throat; This is a spontaneous report from a contactable Nurse reporting for herself. A 62 years old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 30Dec2020 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced would like to know whether the side effects of the COVID vaccine could appear up to 6 days later. The patient had felt aches and sore arm after the vaccine. However, on 05Jan2021 (today) felt really achy, congested, sore throat. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
This case was reported by a physician via sales rep and described the occurrence of injection site pain in a adult female patient who received BEXSERO. On an unknown date, the patient received the 1st dose of BEXSERO (intramuscular) .5 ml. On an unknown date, less than a week after receiving BEXSERO, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. The reporter considered the injection site pain to be related to BEXSERO. Additional details were provided as follows: The patient age not provided by the sales representative. The physician reported to the sale representative that she administered the suspect product to herself and stated that she had very sharp intense pain at the injection site for about a week afterward. While injecting vaccine the physician did not stated that where the vaccine was injected and kept pointing to left arm. The timing of this experience was not known. The physician did not mind being contacted related to this complaint. The office purchases vaccines with both private and public funds. The lot and expiration date of the vaccine was asked to the physician but it was not available for this report.
local erythema, tenderness, swelling, h/a, myalgia biceps lasting 36hr;
Systemic: Nausea-Medium, Systemic: Visual Changes/Disturbances-Severe
Patient reports that he developed loose stools shortly after vaccination. First saw Dr. on 1/3/2012 for this.
Breakthrough case after Covid vaccination. Dose #1 4/2/2021 Dose #2 4/30/2021. C/O runny nose, fatigue, cough, chest pain, and diarrhea/ onset 9/10/2021
01/21/2021 Moderna 1st Dose: New Onset Paroxysmal Atrial Fibrillation/ Flutter rate 160-170  Dizziness, Chest Pain Treatment - Cardizem IV at Emergency Department   02/24/2021 Moderna 2nd Dose: New Onset Paroxysmal Atrial Fibrillation/ Flutter rate 160-170  on day 2 post COVID vaccine Dizziness, Chest Pain Treatment - Cardizem IV       Atrial fib/flutter continued intermittently everyday                                                                                                              Treatment:  Metoprolol, Propafenone, Amiodarone, Pacemaker, Cardiac Ablation
Fever 101.7 within 8 hours of administration, decreased activity, poor po intake, requiring hospitalization to rule-out sepsis given patient age. 3/23/06 Medical records received from hospital which revealed patient experienced fever, tachypnea, & tachycardia./ss
cellulitis diagnosed on 10/25/06 in right arm irregular shaped lesion about 24cm x 14cm along widest points low grade fever numbness & tingling in arm; muscle pain, skin sensitivity Keflex & Bactrim for 10 days Tetnus shot  scheduled for recheck 10/26
cramping, sore calves x 2 wk; falls on steps, flat surfaces, dropping anything trying to carry; unable to get up when fall; affected even hair brushing, unable to open doors, dress self, fix meals; dx GBS-CIDP;
I started having some pain on my left leg on 02/06 and it got bad enough that on 02/07 I went to the urgent care, and they did blood work and an x-ray. Because I am a diabetic and I have neuropathy on my feet the urgent care asked me to go to the ER because they were concerned I had diabetes and did not want to miss anything out.  Urgent care sent out the medical tests to the ER. At the ER they also did another blood work. The tests showed I had elevated blood sugar and elevated white blood cell count. At the ER they diagnosed me with cellulitis. After being seen at the ER I went to see my podiatrist on 02/09 and he looked at the wound site and took out the dressings they put at the ER and he end up lancing at the bottom of the heel and he said it was pretty infected. I noticed some bulging of veins on my leg when I would step on it and he said I might have a deep thrombosis on my leg and the clot did not have anywhere to go so he said that it might be forcing his way out of my heel. After he lanced it and got some fluid out he wrote a referral to have me have outpatient IV therapy for 7 days. After he lanced at my foot and I did the IV therapy I also went to a wound care specialist for the month of February, march, and part of April and that wound is completely healed.
Site: Itching at Injection Site-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Rash Generalized-Mild
Report from patient: Pain at injection site with immunization. Left arm/ right side tingling, weakness, dizziness and vertigo immediately took place. Sat down, drank 8 oz water. Felt weak, Nurse stated looked pale. Weakness and vertigo remained through evening. Emesis x 4 beginning at 10:00 pm, then 11:30pm, 2:00am and 5:00am. Body aches, weakness and increased amounts of nausea throughout the following day along with left side arm pain at injection site. No redness.
neuropathy; polyneuropathy; feeling tingling in my arms/having tingling in my face and all 4 extremities; toes have a burning pain,also feeli it in my fingers; This is a spontaneous report from a contactable consumer (patient). A non pregnant 53-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: FA7485 and expiration date was not reported), via an unspecified route of administration, administered in Arm Right on 10Aug2021 11:30 (at the age of 53-years-old) at unknown dose number single for covid-19 immunization. Medical history included arthritis, dupuytrens nodules, GERD, anxiety. Concomitant medication included calcium carbonate (TUMS  [CALCIUM CARBONATE]) and gummy vitamins received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, patient has not been tested for COVID-19. Patient had no known allergies. On 10Aug2021 14:30, patient started feeling tingling in her arms - by the next day she was having tingling in my face and all 4 extremities. This was still continuing, and now her toes have a burning pain/neuropathy and intermittently and also feeling it in fingers and doctor said it was polyneuropathy. It was unknown if due to vaccine / all blood work were checked out. The adverse events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Patient underwent lab tests and procedures included blood work and having EMG on 20Sep2021. Patient was given treatment for the events. The outcome of the events was not recovered.
I experienced a heavy period which came early. After that I haven't had a period in 6 months. I'm having night sweats, irritably, hot flashes. And I am not pregnant.